Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients?

This publication has 14 references indexed in Scilit:

• Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1α in Neuroblastoma Cells
  Cancer Research, 2006
• TrkB partial agonists: Potential treatment strategy for epilepsy, mania, and autism
  Medical Hypotheses, 2006
• Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1
  Genes & Development, 2005
• A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
  Blood, 2005
• Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
  Blood, 2005
• Shc Family Expression in Neuroblastoma: High Expression of shcC Is Associated with a Poor Prognosis in Advanced Neuroblastoma
  Clinical Cancer Research, 2005
• Identification of Dynamic Proteome Changes Upon Ligand Activation of Trk-Receptors Using Two-dimensional Fluorescence Difference Gel Electrophoresis and Mass Spectrometry
  Molecular & Cellular Proteomics, 2005
• Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
  Nature, 2004
• Die Expression des Neurotrophin-Rezeptors TrkB beeinflusst die Prognose von Nephroblastomen: Ergebnisse einer Pilotstudie
  Klinische Padiatrie, 2001
• Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms’ Tumor
  Journal of Clinical Oncology, 2001